comparemela.com

Latest Breaking News On - Relay therapeutics company profile - Page 2 : comparemela.com

Relay Therapeutics, Inc (NASDAQ:RLAY) Receives Consensus Recommendation of Buy from Analysts

Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) have earned a consensus rating of “Buy” from the six ratings firms that are presently covering the firm, Marketbeat reports. Six research analysts have rated the stock with a buy rating. The average 12 month price target among analysts that have issued a report on […]

Relay Therapeutics (NASDAQ:RLAY) Issues Quarterly Earnings Results

Relay Therapeutics (NASDAQ:RLAY) Issues Quarterly Earnings Results
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Relay Therapeutics (NASDAQ:RLAY) Posts Quarterly Earnings Results, Beats Expectations By $0 08 EPS

Relay Therapeutics (NASDAQ:RLAY) Posts Quarterly Earnings Results, Beats Expectations By $0 08 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Relay Therapeutics (RLAY) to Release Earnings on Thursday

Relay Therapeutics (RLAY) to Release Earnings on Thursday
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Brokerages Set Relay Therapeutics, Inc (NASDAQ:RLAY) PT at $23 69

Brokerages Set Relay Therapeutics, Inc (NASDAQ:RLAY) PT at $23 69
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.